Iodine-123 fluoropropyl-carbomethoxy-3-β-(4-iodophenyltropane) single-photon emission computed tomography findings before and after electroconvulsive therapy in major depressive disorder with Parkinsonism

J ECT. 2011 Dec;27(4):331-3. doi: 10.1097/YCT.0b013e31821646b6.

Abstract

Background: To date, only a few cases of improvement of Parkinsonism in depressed patients treated with electroconvulsive therapy (ECT) have been reported. However, no functional imaging data are available to support this finding.

Objective: To describe the first observation of increase in dopamine transporter uptake after ECT.

Methods: Iodine-123 fluoropropyl-carbomethoxy-3-β-(4-iodophenyltropane) single-photon emission computed tomographic imaging was conducted in a 77-year-old depressed patient displaying symptoms of Parkinson disease (PD) before and after a series of 12 bilateral ECTs.

Results: The patient displayed improvement in PD symptoms and increase in dopamine transporter uptake after ECT.

Conclusions: Our observation suggests that the PD symptoms and decrease in striatal uptake appearing in the context of a depressive episode might warrant further attention, as they might be reversible.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Depressive Disorder, Major / complications*
  • Depressive Disorder, Major / therapy*
  • Dopamine Plasma Membrane Transport Proteins / metabolism
  • Electroconvulsive Therapy*
  • Humans
  • Iodine Radioisotopes*
  • Male
  • Parkinsonian Disorders / complications*
  • Parkinsonian Disorders / therapy*
  • Tomography, Emission-Computed, Single-Photon*
  • Treatment Outcome

Substances

  • Dopamine Plasma Membrane Transport Proteins
  • Iodine Radioisotopes